
Overview
Dr. Mihaela C. Cristea is a UCI Health hematologist oncologist who specializes in the treatment of gynecologic cancers.She earned her medical degree from the University of Medicine and Pharmacy of Iasi, Romania. She completed a residency in internal medicine at Monmouth Medical Center in Long Branch, N.J. She then completed a fellowship in medical oncology at the University of Florida - Health Science Center, Jacksonville.Her research focuses on evaluating novel therapies to improve patient outcomes in gynecologic malignancies. She has contributed to over 50 peer-reviewed publications in prominent medical journals.Cristea, who also speaks Romanian, brings extensive experience to UCI Health Chao Family Comprehensive Cancer Center.
Dr. Cristea is highly rated in 25 conditions, according to our data. Her clinical expertise encompasses Ovarian Cancer, Endometrial Cancer, Lung Cancer, Virilizing Ovarian Tumor, and Endoscopy.
She is actively involved in clinical research, co-authoring 71 peer reviewed articles and participating in 19 clinical trials.
Specialties
Licenses
Fellowships
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
Locations
101 The City Drive South, Building 23, Orange, CA 92868
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
15 Clinical Trials
UCI Health Chao Family Comprehensive Cancer Center
"Dr. Lauren C. Pinter-Brown is a board-certified, fellowship-trained UCI hematologist-oncologist who specializes in the diagnosis and treatment of patients with lymphomas.A nationally recognized expert, Pinter-Brown has a longstanding interest in malignant lymphoma, with a particular focus on T-cell and skin lymphomas. Her clinical interests also include antiphospholipid, B-cell lymphoma, Hodgkin's lymphoma, mycosis fungoides, non-Hodgkins lymphoma, stem-cell transplant and Waldenstrom's disease.She her medical degree at the David Geffen School of Medicine at UCLA Medical School, followed by an internship and residency in internal medicine at Harbor-UCLA Medical Center. She completed a fellowship in hematology and oncology at the Keck School of Medicine at USC.A prolific clinical investigator, Pinter-Brown has made important contributions to several clinical trials that led to approval of new drugs for the treatment of T-cell lymphoma. Her research focus is on optimizing treatment options for patients with lymphoma, especially cutaneous and T-cell lymphomas. Her primary goal is to care for patients through diagnosis, treatment and beyond and to ensure that they are able ""to live their best life.""". Dr. Pinter-Brown is highly rated in 27 conditions, according to our data. Her clinical expertise encompasses T-Cell Lymphoma, Peripheral T-Cell Lymphoma, Non-Hodgkin Lymphoma, Cutaneous T-Cell Lymphoma (CTCL), and Bone Marrow Transplant. Dr. Pinter-Brown is board certified in American Board Of Internal Medicine - Hematology, American Board Of Internal Medicine - Medical Oncology, and American Board Of Internal Medicine - Internal Medicine.
UCI Health Chao Family Comprehensive Cancer Center
Dr. Misako Nagasaka is a board-certified UCI Health oncologist who specializes in the diagnosis and treatment of lung and thyroid cancers. Her clinical interests also early-phase clinical trials, medical ethics and survivorship care for patients.She received her medical degree as well as a PhD from St. Marianna University School of Medicine in Kawasaki, Japan. She completed a residency in internal medicine at Mount Sinai Beth Israel Hospital in New York City, followed by a fellowship in hematology and oncology at Wayne State University School of Medicine's Karmanos Cancer Institute in Detroit, Mich.Her research interests include molecular targeted therapy for lung cancer, immunotherapy and ways to improve patient outcomes. Prior to joining UCI Health, she served as an assistant professor and researcher at Wayne State and the Karmanos institute, she was the principal site investigator on more than 20 lung cancer studies.Nagasaka, who is fluent in Japanese, sees patients at the UCI HealthChao Family Comprehensive Cancer Center in Orange. Dr. Nagasaka is highly rated in 13 conditions, according to our data. Her clinical expertise encompasses Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, EGFR Positive Lung Cancer, Small Cell Lung Cancer (SCLC), and Gastrostomy. Dr. Nagasaka is board certified in American Board Of Internal Medicine - Hematology, American Board Of Internal Medicine - Medical Oncology, and American Board Of Internal Medicine - Internal Medicine. Dr. Nagasaka is currently accepting new patients.
UCI Health Chao Family Comprehensive Cancer Center
Dr. Stefan O. Ciurea is a UCI Health hematologist and director of the Hematopoietic Stem Cell Transplantation and Cellular Therapy Program at the Chao Family Comprehensive Cancer Center.Ciurea earned his medical degree at Grigore T. Popa University of Medicine and Pharmaceuticals in Iasi, Romania. He completed an internal medicine residency at UPMC Pinnacle Harrisburg in Harrisburg, Pa. He then completed a fellowship in hematology-oncology at University of Illinois at Chicago College of Medicine, followed by a fellowship in stem cell transplantation and cellular therapy at the University of Texas MD Anderson Cancer Center in Houston.Before joining the Chao Family Comprehensive Cancer Center to lead its program in hematopoietic stem cell transplantation and cellular therapy, Ciurea served for more than a decade on the faculty of the MD Anderson Cancer Center’s Department of Stem Cell Transplantation and Cellular Therapy.Ciurea is the author of more than 150 peer-reviewed publications and more than 10 book chapters. He also has served as principal investigator on multiple clinical trials, including investigator-initiated trials. He has been invited to speak at more than 50 meetings and conferences around the world, including as keynote speaker. Dr. Ciurea is highly rated in 22 conditions, according to our data. His clinical expertise encompasses Acute Myeloid Leukemia (AML), Graft Versus Host Disease (GvHD), Leukemia, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Ciurea is board certified in American Board Of Internal Medicine - Hematology.
Frequently Asked Questions about Dr. Mihaela C. Cristea
How do I make an appointment with Dr. Mihaela C. Cristea?
You can book an appointment with Dr. Mihaela C. Cristea by calling their office at 714-456-8000. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Mihaela C. Cristea a top-rated expert for Ovarian Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Mihaela C. Cristea is classified as an Elite expert for Ovarian Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Mihaela C. Cristea specialize in?
While Dr. Mihaela C. Cristea is a Hematology, they have specific expertise in Ovarian Cancer, Endometrial Cancer, and Lung Cancer. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology.
Does Dr. Mihaela C. Cristea participate in research or clinical trials?
Yes. Dr. Mihaela C. Cristea has published 71 articles and abstracts on conditions like Ovarian Cancer. You can view a list of Dr. Mihaela C. Cristea's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Mihaela C. Cristea accept my insurance?
Dr. Mihaela C. Cristea accepts most major insurance plans, including Blue Shield of California. We recommend calling the office directly at 714-456-8000 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Ovarian CancerDr. Cristea isElite. Learn about Ovarian Cancer.
- Distinguished
- Adult Soft Tissue SarcomaDr. Cristea isDistinguished. Learn about Adult Soft Tissue Sarcoma.
- Cervical CancerDr. Cristea isDistinguished. Learn about Cervical Cancer.
- Desmoplastic Small Round Cell TumorDr. Cristea isDistinguished. Learn about Desmoplastic Small Round Cell Tumor.
- Endometrial CancerDr. Cristea isDistinguished. Learn about Endometrial Cancer.
- Lung CancerDr. Cristea isDistinguished. Learn about Lung Cancer.
- Malignant Mixed Mullerian TumorDr. Cristea isDistinguished. Learn about Malignant Mixed Mullerian Tumor.
- Non-Small Cell Lung Cancer (NSCLC)Dr. Cristea isDistinguished. Learn about Non-Small Cell Lung Cancer (NSCLC).
- Ovarian CarcinosarcomaDr. Cristea isDistinguished. Learn about Ovarian Carcinosarcoma.
- Pleuropulmonary BlastomaDr. Cristea isDistinguished. Learn about Pleuropulmonary Blastoma.
- Pseudomyxoma PeritoneiDr. Cristea isDistinguished. Learn about Pseudomyxoma Peritonei.
- Sertoli-Leydig Cell TumorDr. Cristea isDistinguished. Learn about Sertoli-Leydig Cell Tumor.
- Small Cell Lung Cancer (SCLC)Dr. Cristea isDistinguished. Learn about Small Cell Lung Cancer (SCLC).
- Testicular Yolk Sac TumorDr. Cristea isDistinguished. Learn about Testicular Yolk Sac Tumor.
- Virilizing Ovarian TumorDr. Cristea isDistinguished. Learn about Virilizing Ovarian Tumor.
- Advanced
- ALK-Positive Non-Small Cell Lung Cancer
- AngiosarcomaDr. Cristea isAdvanced. Learn about Angiosarcoma.
- Bone TumorDr. Cristea isAdvanced. Learn about Bone Tumor.
- EGFR Positive Lung CancerDr. Cristea isAdvanced. Learn about EGFR Positive Lung Cancer.
- Large-Cell Lung CarcinomaDr. Cristea isAdvanced. Learn about Large-Cell Lung Carcinoma.
- Lung AdenocarcinomaDr. Cristea isAdvanced. Learn about Lung Adenocarcinoma.
- Metastatic Pleural TumorDr. Cristea isAdvanced. Learn about Metastatic Pleural Tumor.
- Posterior Fossa TumorDr. Cristea isAdvanced. Learn about Posterior Fossa Tumor.
- Squamous Cell Lung CarcinomaDr. Cristea isAdvanced. Learn about Squamous Cell Lung Carcinoma.
- Triple-Negative Breast CancerDr. Cristea isAdvanced. Learn about Triple-Negative Breast Cancer.
- Experienced
- AgranulocytosisDr. Cristea isExperienced. Learn about Agranulocytosis.
- Appendix CancerDr. Cristea isExperienced. Learn about Appendix Cancer.
- Breast CancerDr. Cristea isExperienced. Learn about Breast Cancer.
- Colorectal CancerDr. Cristea isExperienced. Learn about Colorectal Cancer.
- Congenital Aplastic AnemiaDr. Cristea isExperienced. Learn about Congenital Aplastic Anemia.
- EndoscopyDr. Cristea isExperienced. Learn about Endoscopy.
- Epithelioid SarcomaDr. Cristea isExperienced. Learn about Epithelioid Sarcoma.
- Fanconi AnemiaDr. Cristea isExperienced. Learn about Fanconi Anemia.
- FibrosarcomaDr. Cristea isExperienced. Learn about Fibrosarcoma.
- Inflammatory Breast CancerDr. Cristea isExperienced. Learn about Inflammatory Breast Cancer.
- LiposarcomaDr. Cristea isExperienced. Learn about Liposarcoma.
- Lymphofollicular HyperplasiaDr. Cristea isExperienced. Learn about Lymphofollicular Hyperplasia.
- MelanomaDr. Cristea isExperienced. Learn about Melanoma.
- MesenchymomaDr. Cristea isExperienced. Learn about Mesenchymoma.
- MesotheliomaDr. Cristea isExperienced. Learn about Mesothelioma.
- Metastatic Brain TumorDr. Cristea isExperienced. Learn about Metastatic Brain Tumor.
- Myxoid LiposarcomaDr. Cristea isExperienced. Learn about Myxoid Liposarcoma.
- Neuroendocrine TumorDr. Cristea isExperienced. Learn about Neuroendocrine Tumor.
- Primitive Neuroectodermal Tumor (PNET)Dr. Cristea isExperienced. Learn about Primitive Neuroectodermal Tumor (PNET).
- Pulmonary EmbolismDr. Cristea isExperienced. Learn about Pulmonary Embolism.
- Rhabdomyosarcoma EmbryonalDr. Cristea isExperienced. Learn about Rhabdomyosarcoma Embryonal.
- Shwartzman PhenomenonDr. Cristea isExperienced. Learn about Shwartzman Phenomenon.
- Synovial SarcomaDr. Cristea isExperienced. Learn about Synovial Sarcoma.
- Testicular CancerDr. Cristea isExperienced. Learn about Testicular Cancer.
- ThrombocytopeniaDr. Cristea isExperienced. Learn about Thrombocytopenia.
- Thymic Epithelial TumorDr. Cristea isExperienced. Learn about Thymic Epithelial Tumor.
- Undifferentiated Pleomorphic SarcomaDr. Cristea isExperienced. Learn about Undifferentiated Pleomorphic Sarcoma.
- Urothelial CancerDr. Cristea isExperienced. Learn about Urothelial Cancer.
- Vaginal CancerDr. Cristea isExperienced. Learn about Vaginal Cancer.
- Venous Thromboembolism (VTE)Dr. Cristea isExperienced. Learn about Venous Thromboembolism (VTE).
- Vulvar CancerDr. Cristea isExperienced. Learn about Vulvar Cancer.


